Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Osiris Loss Narrower Than Expected
Yahoo/Zacks
Thursday, August 2, 2012 - 10:24am
tags:
earnings, Osiris
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thursday, August 2, 2012 - 10:22am
tags:
cystic fibrosis, Vertex Pharma, AstraZeneca, Gilead, Kalydeco, Pfizer, Rigel Pharmaceuticals, VX-809
Loss at HGSI Wider Than Expected
Yahoo/Zacks
Thursday, August 2, 2012 - 10:20am
tags:
earnings, Human Genome Sciences
Bristol-Myers: hepatitis C drug trial hit by safety issue
Reuters
Thursday, August 2, 2012 - 10:19am
tags:
Bristol-Myers Squibb, hepatitis C, BMS-986094
Dendreon Approaching End Of Road, While Other Immunotherapies Thrive
Seeking Alpha
Wednesday, August 1, 2012 - 11:08am
tags:
Dendreon, Galena Biopharma
Shire calms jitters on ADHD drug growth
Reuters
Wednesday, August 1, 2012 - 11:03am
tags:
ADHD, Shire, earnings
Allergan Earnings: Profit and Revenue Rises, Yet Short of Estimates
Wall St. Cheat Sheet
Wednesday, August 1, 2012 - 10:21am
tags:
earnings, Allergan
6 Healthcare Stocks With Pending August Catalysts
Seeking Alpha
Wednesday, August 1, 2012 - 10:08am
tags:
Abbott Labs, Amgen, Amarin, Arena Pharmaceuticals, Gilead, JNJ, Pfizer, Horizon Pharma, Vivus, Regeneron, Sanofi, Talon Therapeutics
On Safety, Vivus Vs. Arena
Seeking Alpha
Wednesday, August 1, 2012 - 9:56am
tags:
Vivus, Arena, Belviq, Qsymia, obesity
Bayer’s Yasmin Lawsuit Settlements Rise To $402.6 Million
Bloomberg
Wednesday, August 1, 2012 - 9:52am
tags:
settlements, Bayer, Yasmin
Pressure Grows On Pfizer To Abandon Heartland
Pharmalot
Wednesday, August 1, 2012 - 9:49am
tags:
Pfizer, Heartland Institute
4 Reasons To Buy Zalicus
Seeking Alpha
Wednesday, August 1, 2012 - 9:48am
tags:
Zalicus, Novartis, Sanofi
Vivus Holds Strong Patent Portfolio For Qsymia
Seeking Alpha
Wednesday, August 1, 2012 - 7:54am
tags:
obesity, Qsymia, Vivus, patents
Can Dendreon Be Saved?
Motley Fool
Wednesday, August 1, 2012 - 7:52am
tags:
Dendreon
3 Analyst-Backed Pharmaceutical Stocks With Great Projections
Seeking Alpha
Wednesday, August 1, 2012 - 7:52am
tags:
Keryx, Rigel Pharmaceuticals, Aegerion
Pfizer Animal Health IPO, Cost Cuts Yield Time To Reinvent Its Research
Bloomberg
Wednesday, August 1, 2012 - 7:50am
tags:
Pfizer, animal health, IPOs
Depomed announces submission of Serada NDA
Yahoo/Fly on the Wall
Tuesday, July 31, 2012 - 7:20pm
tags:
Serada, Depomed, hot flashes
Amarin falls 11% on insider stock-sale reports
Marketwatch
Tuesday, July 31, 2012 - 7:17pm
tags:
Amarin, fish oil, Vascepa
Pfizer study: Arthritis pill beats standard drug
Yahoo/AP
Tuesday, July 31, 2012 - 7:15pm
tags:
arthritis, Pfizer, tofacitinib
GlaxoSmithKline shipping U.S. flu vaccine with new strain coverage recommended for 2012-2013
Yahoo
Tuesday, July 31, 2012 - 7:13pm
tags:
Flu, influenza, vaccines, GSK, flu vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.